The Venture Codex Logo

The Venture Codex

Bristol Myers Squibb

430 E 29th St, New York, NY, 10016, United States

Overview

Pharmaceuticals and nutritional products discovery and development.

Founded

1887

Deals · 12mo

4

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series A
Series B
Series C

Geographic focus

United Kingdom
United States

Sector focus

Biotechnology
Health Care
Medical
Pharmaceutical
...

Investment portfolio

69rounds
NAMEDATESIZE
Link Cell Therapies
Sep 2026Participated
$30 MSeries A
Ratio Therapeutics
Jul 2026Participated
$70 MSeries C
Beeline Medicines
Jun 2026Participated
$126 MSeries A
Precede Biosciences
Jan 2026Participated
$84 MSeries B
Beeline Medicines
Jul 2025Participated
$300 MSeries A
Dispatch Bio
Jul 2025Participated
$216 MSeries A
Be Biopharma
Jan 2025Participated
$92 MSeries C
Light Horse Therapeutics
Jan 2025Participated
$62 MSeries A
Nuvig Therapeutics
Dec 2024Participated
$161 MSeries B
Be Biopharma
Oct 2024Participated
$82 MOther Equity
Aktis Oncology
Sep 2024Participated
$175 MSeries B
ArsenalBio
Sep 2024Participated
$325 MSeries C
Link Cell Therapies
Sep 2026Participated
$30 MSeries A
Ratio Therapeutics
Jul 2026Participated
$70 MSeries C
Beeline Medicines
Jun 2026Participated
$126 MSeries A
Precede Biosciences
Jan 2026Participated
$84 MSeries B
Beeline Medicines
Jul 2025Participated
$300 MSeries A
Dispatch Bio
Jul 2025Participated
$216 MSeries A
Be Biopharma
Jan 2025Participated
$92 MSeries C
Light Horse Therapeutics
Jan 2025Participated
$62 MSeries A
Nuvig Therapeutics
Dec 2024Participated
$161 MSeries B
Be Biopharma
Oct 2024Participated
$82 MOther Equity
Aktis Oncology
Sep 2024Participated
$175 MSeries B
ArsenalBio
Sep 2024Participated
$325 MSeries C
69
Items
...
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Bristol Myers Squibb: 69 funding rounds are recorded in the selected participation categories.All available history.
Bristol Myers Squibb: 69 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series A319
Series B323
Series C+014
Other Equity06
Debt01

Monthly Deal Activity

Bristol Myers Squibb: 69 deals are recorded across 125 months.All available history.
Bristol Myers Squibb: 69 deals are recorded across 125 months. All available history
MonthDeals
Jun '161
Jul '160
Aug '160
Sep '160
Oct '160
Nov '160
Dec '160
Jan '170
Feb '170
Mar '170
Apr '170
May '171
Jun '170
Jul '170
Aug '170
Sep '170
Oct '170
Nov '170
Dec '171
Jan '182
Feb '180
Mar '180
Apr '180
May '180
Jun '180
Jul '180
Aug '180
Sep '180
Oct '181
Nov '180
Dec '181
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '191
Dec '190
Jan '200
Feb '200
Mar '201
Apr '200
May '201
Jun '201
Jul '200
Aug '200
Sep '201
Oct '200
Nov '200
Dec '200
Jan '211
Feb '211
Mar '213
Apr '211
May '212
Jun '210
Jul '212
Aug '211
Sep '212
Oct '210
Nov '212
Dec '210
Jan '222
Feb '220
Mar '220
Apr '222
May '222
Jun '222
Jul '221
Aug '221
Sep '223
Oct '220
Nov '221
Dec '220
Jan '231
Feb '230
Mar '231
Apr '231
May '230
Jun '230
Jul '230
Aug '231
Sep '231
Oct '231
Nov '230
Dec '230
Jan '242
Feb '241
Mar '241
Apr '244
May '240
Jun '240
Jul '241
Aug '241
Sep '242
Oct '241
Nov '240
Dec '241
Jan '252
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '252
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '261
Feb '260
Mar '260
Apr '260
May '260
Jun '261
Jul '261
Aug '260
Sep '261
Oct '260

Sector Breakdown

Bristol Myers Squibb: Health & Life Sciences is the largest displayed sector by deal count (67 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Bristol Myers Squibb: Health & Life Sciences is the largest displayed sector by deal count (67 deals). All available history
SectorDeals
Health & Life Sciences67
AI & Machine Learning6
Enterprise Software3
Manufacturing2
Data, Analytics & IT2
Space & Frontier Tech2
Networks, Cloud & Communication1
Professional Services1

Deal Size Distribution

Bristol Myers Squibb: 69 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Bristol Myers Squibb: 69 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M4
$25M-$50M8
$50M-$100M33
$100M-$250M20
$250M-$500M3
$500M-$1B0
$1B+0

Deals By Geography

Bristol Myers Squibb: United States has the largest recorded deal count among the displayed regions (57 deals).All available history.

Top 2 of 2 regions; European countries are grouped as Europe.

Bristol Myers Squibb: United States has the largest recorded deal count among the displayed regions (57 deals). All available history
RegionDeals
United States57
Europe12
Bristol Myers Squibb: 20 co-investors are shown, with Alexandria Venture Investments sharing 14 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Bristol Myers Squibb: 20 co-investors are shown, with Alexandria Venture Investments sharing 14 recorded deals. All available history
Co-investorShared deals
Alexandria Venture Investments14
RA Capital Management12
ARCH Venture Partners9
Novo Holdings8
Atlas Venture7
Pfizer Ventures7
Cowen Healthcare Investments6
Novartis6
Samsara BioCapital6
Surveyor Capital6
Deep Track Capital5
Eli Lilly and Company5
GT Healthcare Capital Partners5
Janus Henderson Investors5
Johnson & Johnson Innovation5
OrbiMed5
Section 325
Takeda Ventures5
AbbVie Ventures4
BVF Partners4

Investment Strategy

Bristol Myers Squibb: Led accounts for 9% and participating for 91% of round participation.All available history.
Bristol Myers Squibb: Led accounts for 9% and participating for 91% of round participation. All available history
CategoryDeals (count)Share (%)
Led69%
Participating6391%
Bristol Myers Squibb: Single-lead accounts for 17% and co-led for 83% of lead dynamics.All available history.
Bristol Myers Squibb: Single-lead accounts for 17% and co-led for 83% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead117%
Co-led583%

Team

Chris Boerner

Executive Vice President, Chief Commercialization Officer

Douglas Kou

Co-Chair Observational Protocol Review Committee

Frédéric Baribaud

Academic Research Collaboration Lead

Hommy Almonte

Immuno-Oncology Field Sales Trainer

John damonti

Foundation President

Kristin Weed

Senior Territory Business Manager, Dermatology - Rockville, MD

Mita Maity

Research Scientist

Sandra Leung

Senior Vice President, General Counsel & Secretary